Lam Karen C

VP, Finance and Controller at RAPT Therapeutics, Inc.

Sold, on record
$116k
Dollars the filings state
Form 4 sales
3
Latest Nov 2, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale RAPT Therapeutics, Inc.Plan not stated
    May 7 2020

    Sold 1,831 shares at $15.40 ($28k)

    Lam Karen C, VP, Finance & Controller

    Sold 14.5% of holdings ($195k position)10,833 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale RAPT Therapeutics, Inc.Plan not stated
    Jun 25 +49 days

    Sold 875 shares at $35.00 ($31k)

    Lam Karen C, VP, Finance & Controller

    Sold 6.4% of holdings ($476k position)12,735 shares leftFiling

  3. 3 Form 4 sale RAPT Therapeutics, Inc.Plan not stated
    Nov 2 +130 days

    Sold 2,022 shares at $28.14 ($57k)

    Lam Karen C, VP, Finance and Controller

    Sold 13.7% of holdings ($415k position)12,735 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Lam Karen C
Source
Nov 2, 2020RAPT Therapeutics, Inc.VP, Finance and ControllerForm 4 sale2,022$57k13.7%Plan not statedSEC
Jun 25, 2020RAPT Therapeutics, Inc.VP, Finance & ControllerForm 4 sale875$31k6.4%Plan not statedSEC
May 7, 2020RAPT Therapeutics, Inc.VP, Finance & ControllerForm 4 sale1,831$28k14.5%Plan not statedSEC